Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating a regimen of metformin plus empagliflozin with sitagliptin versus linagliptin in adults with Type 2 Diabetes Mellitus, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucophage (metformin)
  • Januvia (sitagliptin)
  • Jardiance (empagliflozin)
  • Tradjenta (Linagliptin)

Snippet

Sponsor: Bahria University | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: ENROLLING_BY_INVITATION